[Emergency coronary artery bypass grafting in patients with severe pump failure complicating acute myocardial

K Sakai1, S Sakaki, N Hirata

  • 1Division of Cardiovascular Surgery, Sakurabashi Watanabe Hospital, Osaka, Japan.

[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai
|December 1, 1992
PubMed

Insights

Emergency coronary bypass grafting improved cardiac function in patients with severe pump failure after myocardial infarction. Both large myocardial infarction and severe ischemia groups showed significant hemodynamic improvements post-surgery.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Cardiac Rehabilitation

Context:

  • Severe pump failure complicates acute myocardial infarction (MI).
  • Emergency coronary artery bypass grafting (CABG) is a treatment option.
  • Understanding the mechanisms of pump failure is crucial for treatment efficacy.

Purpose:

  • To evaluate the effectiveness of emergency coronary artery bypass grafting (CABG) in patients with severe pump failure post-myocardial infarction (MI).
  • To compare outcomes between patients with large MI alone versus those with severe ischemia.
  • To assess changes in cardiac index (CI) and pulmonary wedge pressure (PCWP) post-CABG.

Summary:

  • Thirty patients with severe pump failure (Killip's III+) post-MI underwent emergency CABG.
  • Patients were divided into Group I (large MI) and Group II (severe ischemia).
  • Both groups showed significant improvements in CI and PCWP 72 hours post-surgery, with no significant difference between groups.

Impact:

  • Emergency CABG can effectively improve hemodynamic function in severe pump failure post-MI.
  • The study suggests CABG is beneficial regardless of the specific mechanism of pump failure (MI vs. ischemia).
  • Further research may explore long-term outcomes and refine patient selection for CABG in this population.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...